尼日利亚的疟疾疫苗实施:解决国家免疫计划中覆盖面的挑战,以实现高影响力免疫接种
Ibrahim Adebayo Hassan1, Jeremiah Babatunde Araoye2, Dimeji Abdulsobur Olawuyi3
1Faculty of Pharmacy, Obafemi Awolowo University, Ile-Ife, Nigeria.
Vaccine
|June 12, 2025
概括
尼日利亚 尼日利亚 尼日利亚
科学领域:
- 全球卫生健康 全球卫生健康
- 疫苗学 疫苗学 疫苗学
- 公共卫生政策 公共卫生政策
背景情况:
- 疟疾仍然是一个重大的全球健康威胁,特别是在5岁以下的儿童中.
- 尼日利亚的疟疾负担最高,在2023年5岁以下儿童死亡率为38.4%,有720万名风险新生儿.
- 到2025年引入R21疟疾疫苗为尼日利亚提供了一个关键的机会.
研究的目的:
- 讨论尼日利亚疟疾疫苗实施前景.
- 确定影响疫苗推广的现有国家免疫计划 (NPI) 中的挑战.
- 提出改善NPI绩效的优先领域,以确保高影响力疟疾疫苗的实施.
主要方法:
- 审查有关疟疾疫苗实施和免疫覆盖范围的现有证据.
- 分析尼日利亚有效免疫接种障碍 (需求和供应方面).
- 确定NPI改进的四个关键领域:覆盖范围最大化,社会动员,计划管理和进展监测.
主要成果:
- 由于目前的NPI绩效问题,尼日利亚在实现高影响力疟疾疫苗实施方面面临重大挑战.
- 尼日利亚有大量未免疫和免疫不足的儿童.
- 在需求和供应方面,有效免疫覆盖的障碍普遍存在.
结论:
- 尼日利亚成功实施疟疾疫苗取决于加强NPI.
- 优先考虑NPI中的覆盖范围最大化,社会动员,计划管理和进度监测是必不可少的.
- 需要根据尼日利亚环境量身定制的基于证据的战略,以克服免疫覆盖面的挑战,并最大限度地提高疫苗的影响.
更多相关视频
09:57Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
Published on: August 6, 2020
6.4K
05:28Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
2.9K
相关概念视频
Vaccinations
Overview
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
